Related Experiment Videos
Epidermal growth factor receptors in normal and neoplastic thyroid tissue
Surgery
|December 1, 1985
Summary
Epidermal growth factor (EGF) receptors are present in both normal and cancerous thyroid tissues. Higher EGF receptor binding in thyroid tumors may correlate with a poorer prognosis, suggesting a role in cancer progression.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Epidermal growth factor (EGF) is known to stimulate thyroid cell proliferation.
- The role of EGF in regulating normal and neoplastic thyroid cell growth requires further investigation.
Purpose of the Study:
- To investigate the presence and characteristics of EGF receptors in paired normal and neoplastic human thyroid tissues.
- To determine if EGF receptor levels correlate with thyroid tumor prognosis.
Main Methods:
- Radioreceptor assay using 125I-labeled EGF to quantify EGF receptor binding.
- Analysis of paired normal and neoplastic thyroid tissue samples from eight patients.
- Competitive inhibition studies to confirm EGF receptor specificity.
Main Results:
- High-affinity, saturable, and specific binding of EGF was observed in both normal and neoplastic thyroid tissue particulate fractions.
- EGF receptor binding was significantly higher in neoplastic thyroid tissue compared to normal tissue (p < 0.05).
- Thyroid tumors with poorer prognoses exhibited higher EGF binding relative to adjacent normal tissue than tumors with better prognoses.
Conclusions:
- EGF receptors are present and functional in human thyroid tissues.
- Increased EGF receptor expression in thyroid neoplasms suggests a potential role in tumor growth and progression.
- Characterization of EGF receptors may serve as a biomarker for predicting the clinical course of malignant thyroid neoplasms.